Pharmaceutical - Gastro-intestinals

Filter

Current filters:

Gastro-intestinals

Popular Filters

1 to 25 of 180 results

UPDATE: Valeant ups bid for Salix by 9.5%, which is accepted

UPDATE: Valeant ups bid for Salix by 9.5%, which is accepted

16-03-2015

As had been widely expected, acquisitive Canadian drugmaker Valeant Pharmaceutical International has…

Endo InternationalGastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceutical International

NICE recommends AbbVie's Humira and Merck's Remicade and Simponi for ulcerative colitis

NICE recommends AbbVie's Humira and Merck's Remicade and Simponi for ulcerative colitis

25-02-2015

The UK’s health regulator, the National Institute for Health and Care Excellence (NICE) has recommended…

AbbVieGastro-intestinalsHumiraMerck & CoPharmaceuticalRegulationRemicadeSimponi InjectionUK

UPDATE: Valeant confirms $10 billion offer for Salix

UPDATE: Valeant confirms $10 billion offer for Salix

23-02-2015

Acquisitive Canadian drugmaker Valeant Pharmaceutical International late Sunday confirmed it has reached…

Gastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceuticals International

Valeant in final stages of making $10 billion offer for Salix; reports

Valeant in final stages of making $10 billion offer for Salix; reports

22-02-2015

Acquisitive Canadian drugmaker Valeant Pharmaceutical International could announce an around $10 billion…

Gastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceuticals International

Takeda links with a London university to develop novel gastroenterology products

Takeda links with a London university to develop novel gastroenterology products

22-02-2015

The UK’s Queen Mary University of London (QMUL) and Takeda Pharmaceutical, Japan’s largest drugmaker,…

Gastro-intestinalsPharmaceuticalResearchTakeda PharmaceuticalUKUniversity of London

Ferring launches Cortiment in Europe and publishes new efficacy data

Ferring launches Cortiment in Europe and publishes new efficacy data

20-02-2015

Switzerland-headquartered privately-held pharma company Ferring has announced the European launch Cortiment…

CortimentEuropeFerringGastro-intestinalsMarkets & MarketingPharmaceuticalResearch

VBL Therapeutics shares slide as it ends VB-201 development in two indications

VBL Therapeutics shares slide as it ends VB-201 development in two indications

18-02-2015

Shares in Israeli drugmaker VBL Therapeutics dropped up to 55% after it said that it would discontinue…

Gastro-intestinalsIsraelOncologyPharmaceuticalResearchVBL Therapeutics

AstraZeneca to pay $7.9 million to resolve kickback allegations in USA

AstraZeneca to pay $7.9 million to resolve kickback allegations in USA

12-02-2015

Anglo-Swedish pharma major AstraZeneca has agreed to pay the US government $7.9 million to settle allegations…

AstraZenecaCardio-vascularGastro-intestinalsLegalMarkets & MarketingNexiumPharmaceuticalPlendilPrilosecToprol XLUSA

Helsinn signs exclusive agreement with Mundipharma for distribution of anamorelin

Helsinn signs exclusive agreement with Mundipharma for distribution of anamorelin

11-02-2015

Swiss oncology specialist Helsinn has signed an exclusive agreement with Mundipharma to distribute and…

anamorelinGastro-intestinalsHelsinnLicensingMarkets & MarketingMundipharmaOncologyPharmaceutical

Helsinn partners with Mundipharma to commercialize NEPA in Brazil

Helsinn partners with Mundipharma to commercialize NEPA in Brazil

09-02-2015

Swiss oncology specialist Helsinn has signed an exclusive agreement with Mundipharma for the distribution…

BrazilGastro-intestinalsHelsinnLicensingMundipharmaNEPAPharmaceutical

US DEA de-schedules AstraZeneca’s Movantik

07-02-2015

The USA’s Drug Enforcement Administration (DEA) has de-scheduled UK pharma major AstraZeneca’s Movantik…

AstraZenecaGastro-intestinalsMovantiknaloxegolNektar TherapeuticsPharmaceuticalRegulationUSA

Applied Molecular Transport inks research and license agreement with Janssen on IBD therapy

Applied Molecular Transport inks research and license agreement with Janssen on IBD therapy

28-01-2015

Biopharma company Applied Molecular Transport has entered into a research collaboration and license agreement…

Applied Molecular TransportGastro-intestinalsJanssenJohnson & JohnsonLicensingPharmaceutical

AstraZeneca files marketing authorization application with EMA for lesinurad

AstraZeneca files marketing authorization application with EMA for lesinurad

22-01-2015

The European Medicines Agency has accepted the marketing authorization application by AstraZeneca for…

AstraZenecaGastro-intestinalslesinuradPharmaceuticalRegulation

FDA committee votes to not recommend Ferring’s desmopressin

FDA committee votes to not recommend Ferring’s desmopressin

15-01-2015

The US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has…

desmopressinFerring PharmaceuticalsGastro-intestinalsPharmaceuticalRegulationUSA

Tenfold growth by 2023 forecast for celiac disease drug market

Tenfold growth by 2023 forecast for celiac disease drug market

08-01-2015

The celiac disease treatment market value will expand more than tenfold from an estimated $49.6 million…

AbbVieEuropeGastro-intestinalslarazotide acetatelatiglutenaseMarkets & MarketingPharmaceuticalTeva Pharmaceutcal IndustriesUSA

Insulin therapeutics specialist Nutrinia completes $12 million financing round

Insulin therapeutics specialist Nutrinia completes $12 million financing round

18-12-2014

Nutrinia, a developer of oral insulin therapies to treat rare gastrointestinal disorders in babies, has…

Business FinanceEndocrine systemGastro-intestinalsNutriniaPharmaceutical

Janssen returns rights of IBD drug GLPG1205 to Galapagos

Janssen returns rights of IBD drug GLPG1205 to Galapagos

17-12-2014

US health care giant Johnson & Johnson’s Europe-based subsidiary Janssen has returned the rights to…

GalapagosGastro-intestinalsJanssenJanssen PharmaceuticaLicensingPharmaceutical

NICE says ‘yes’ to Remicade, Humira and Simponi for ulcerative colitis

NICE says ‘yes’ to Remicade, Humira and Simponi for ulcerative colitis

12-12-2014

UK health care cost watchdog the National Institute for Health and Care Excellence (NICE) has issued…

AbbVieGastro-intestinalsHumiraMerck & CoPharmaceuticalPricingRegulationRemicadeSimponi InjectionUK

Takeda partners with Monash University on gastrointestinal research

Takeda partners with Monash University on gastrointestinal research

10-12-2014

Japan’s largest drugmaker Takeda has entered into a research partnership with the Monash Institute…

AustraliaGastro-intestinalsPharmaceuticalResearchTakeda Pharmaceuticals

AstraZeneca’s Moventig gains EU approval for OIC

09-12-2014

The European Commission has granted marketing authorization for Anglo-Swedish pharma major AstraZeneca’s…

AstraZenecaEuropeGastro-intestinalsMoventigNektar TherapeuticsPharmaceuticalRegulation

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

02-12-2014

French drug major Sanofi and North Carolina-based pharma company Pozen have agreed to end their collaboration…

FranceGastro-intestinalsLicensingPA8140/PA32540PharmaceuticalPozenSanofiUSA

Ulcerative colitis market to hit $4.2 billion by 2023

Ulcerative colitis market to hit $4.2 billion by 2023

13-11-2014

The ulcerative colitis market is set to grow from $2.7 billion in 2013 to $4.2 billion in 2023 in the…

Decision Resources GroupEntyvioGastro-intestinalsGlobalMarkets & MarketingPharmaceuticalRemicadeResearchXeljanz

District Court sets accelerated date to resolve Takeda suit against FDA over Colcrys

District Court sets accelerated date to resolve Takeda suit against FDA over Colcrys

10-11-2014

The US District Court for the District of Columbia, presiding in a law suit between Japanese drugmaker…

ColcrysGastro-intestinalsHikmaLegalPharmaceuticalTakeda PharmaceuticalUSAWest-Ward

1 to 25 of 180 results

Back to top